Clinical Trials
2
Active:0
Completed:1
Trial Phases
1 Phases
Phase 4:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 4
1 (100.0%)A Survey Study to Assess the Impact of the COVID-19 Pandemic on Participants With Pre-Existing Mental Health Diagnosis
- Conditions
- Covid19
- First Posted Date
- 2020-09-29
- Last Posted Date
- 2020-10-14
- Lead Sponsor
- Siyan Clinical Corporation
- Target Recruit Count
- 1000
- Registration Number
- NCT04568135
A 10-Week, Open-Label, Flexible Dose Adaptive Study Evaluating the Efficacy of Vortioxetine in Subjects With Panic Disorder
- First Posted Date
- 2015-03-23
- Last Posted Date
- 2016-07-25
- Lead Sponsor
- Siyan Clinical Corporation
- Target Recruit Count
- 27
- Registration Number
- NCT02395510
- Locations
- 🇺🇸
Siyan Clinical Corporation, Santa Rosa, California, United States
News
No news found